You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Express Scripts
Medtronic
McKesson
Colorcon

Last Updated: March 29, 2020

DrugPatentWatch Database Preview

Formulation information for generic ingredient: FINGOLIMOD HYDROCHLORIDE


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Ocrelizumab

CASRN: 637334-45-3

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Boehringer Ingelheim
Merck
Dow
McKinsey